Skip to main content

Vyome Holdings, Inc

HIND
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001427570

No open-market purchases or sales by Vyome Holdings, Inc insiders were filed in the last 90 days; 12 institutions reported holding it in 13F filings for Q2 2026, worth $296.5K in total; no superinvestor holds it.

Q2 2023 vs. Q1 2023

How the institutions holding Vyome Holdings, Inc changed between Q1 2023 and Q2 2023.

All holders in Q2 2023All holders in Q1 2023

13F holders of HIND: Q1 2023 compared with Q2 2023
MeasureQ1 2023Q2 2023Change
Holders1311−2
Shares144.0K103.7K−40.3K (−28.0%)
Value$370.3K$153.5K−$216.8K (−58.6%)

New holders (1)

Institutions that held Vyome Holdings, Inc at the end of Q2 2023 but not at the end of Q1 2023.

Institutions new to HIND in Q2 2023
InstitutionSharesValue% of portfolio
Cornerstone Planning Group LLC135$2000.00%

Sold out (3)

Institutions that held Vyome Holdings, Inc at the end of Q1 2023 and filed for Q2 2023 without it.

Institutions that sold out of HIND in Q2 2023
InstitutionShares, Q1 2023Value, Q1 2023
Sabby Management, LLC74,583$191.7K
BerganKDV Wealth Management, LLC275$707
Transamerica Financial Advisors, Inc.2–